BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC

June 14, 2024 – The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) as its “Stock to Study” and Medtronic PLC (NYSE: MDT) as its “Undervalued Stock” in the September 2024 issue for investors’ informational and educational use.

“With GameStop back in the headlines, the siren song of easy money has returned, luring the unschooled down treacherous paths. The National Association of Investors counsels everyday Americans seeking long term wealth to focus on fundamentals and learn to earn,” said Ken Zendel, CEO of National Association of Investors Corp. (NAIC), the parent organization of BetterInvesting.
 
For a refresher on GameStop vs. the fundamentals, read:
https://www.betterinvesting.org/learn-about-investing/investor-education/investing/market-madness-short-selling-short-squeeze
 
Check the September 2024 issue of BetterInvesting Magazine for more details about the latest stocks. Non-members can utilize the limited, trial version of the BetterInvesting online stock selection and analysis tools to study the investment potential of Amphastar Pharmaceuticals and Medtronic by viewing their fundamental data and applying judgments.

Committee members are Dan Rutter, CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; and Anne Nichols, CFA; Lauren Adams, CFA.

As stated, the BetterInvesting committee’s Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.  Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.